tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
RenovoRx expands RenovoCath commercial adoption to nine cancer centers
PremiumThe FlyRenovoRx expands RenovoCath commercial adoption to nine cancer centers
23d ago
RenovoRx to announce new clinical data from Phase III TIGeR-PaC trial
Premium
The Fly
RenovoRx to announce new clinical data from Phase III TIGeR-PaC trial
1M ago
RenovoRx Receives Nasdaq Notice for Bid Price Noncompliance
Premium
Company Announcements
RenovoRx Receives Nasdaq Notice for Bid Price Noncompliance
1M ago
RenovoRx files $50M mixed securities shelf
PremiumThe FlyRenovoRx files $50M mixed securities shelf
3M ago
RenovoRx price target lowered to $3 from $3.50 at Alliance Global
Premium
The Fly
RenovoRx price target lowered to $3 from $3.50 at Alliance Global
3M ago
RenovoRx Reports Q3 2025 Earnings and Business Growth
Premium
Company Announcements
RenovoRx Reports Q3 2025 Earnings and Business Growth
3M ago
RenovoRx’s PanTheR Registry Trial: A New Frontier in Tumor Treatment
PremiumCompany AnnouncementsRenovoRx’s PanTheR Registry Trial: A New Frontier in Tumor Treatment
4M ago
RenovoRx’s Innovative Approach in Pancreatic Cancer Treatment: A Clinical Study Update
Premium
Company Announcements
RenovoRx’s Innovative Approach in Pancreatic Cancer Treatment: A Clinical Study Update
4M ago
RenovoRx expands Scientific Advisory Board with appointment of Baere
Premium
The Fly
RenovoRx expands Scientific Advisory Board with appointment of Baere
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100